Miyamoto H - Search Results

1

The flow cytometric nuclear-DNA content, tumor-origin, nuclear size and prognosis in squamous-cell lung-cancer.

Miyamoto H, Isobe H, Akita H, Ishiguro A, Endo T, Inoue S, Kawakami Y. Miyamoto H, et al. Int J Oncol. 1992 Aug;1(3):325-9. doi: 10.3892/ijo.1.3.325. Int J Oncol. 1992. PMID: 21584550

2

Accuracy of the bronchoscopic DNA content analysis of non-small-cell lung carcinoma.

Haneda H, Miyamoto H, Isobe H, Abe S, Akita H, Ishikuro A, Kawakami Y, Okayasu K, Endo T, Inoue K. Haneda H, et al. Among authors: miyamoto h. J Surg Oncol. 1992 Mar;49(3):182-8. doi: 10.1002/jso.2930490311. J Surg Oncol. 1992. PMID: 1312655

3

A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.

Miyamoto H, Nakabayashi T, Isobe H, Akita H, Kawakami Y, Arimoto T, Asakawa M, Suzuki A, Fujikane T, Shimizu T, et al. Miyamoto H, et al. Oncology. 1992;49(6):431-5. doi: 10.1159/000227087. Oncology. 1992. PMID: 1334539 Clinical Trial.

4

The relationship of the proliferating cell nuclear antigen protein to cis-diamminedichloroplatinum (II) resistance of a murine leukemia cell line P388/CDDP.

Haneda H, Katabami M, Miyamoto H, Isobe H, Shimizu T, Ishiguro A, Moriuti T, Takasaki Y, Kawakami Y. Haneda H, et al. Among authors: miyamoto h. Oncology. 1991;48(3):234-8. doi: 10.1159/000226934. Oncology. 1991. PMID: 2023704

5

Flow cytometric DNA content analysis in primary lung cancer: comparison of results from fresh and paraffin-embedded specimens.

Isobe H, Miyamoto H, Inoue K, Shimizu M, Endo T, Mizuno S, Kawakami Y. Isobe H, et al. Among authors: miyamoto h. J Surg Oncol. 1990 Jan;43(1):36-9. doi: 10.1002/jso.2930430110. J Surg Oncol. 1990. PMID: 2296195

6

Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.

Miyamoto H, Harada M, Isobe H, Akita HD, Haneda H, Yamaguchi E, Kuzumaki N, Kawakami Y. Miyamoto H, et al. Cancer Res. 1991 Dec 1;51(23 Pt 1):6346-50. Cancer Res. 1991. PMID: 1657384

7

Concurrent chemotherapy and thoracic radiation therapy for limited-stage small cell lung cancer.

Dosakaakita H, Miyamoto H, Nakabayashi T, Sasaki S, Arimoto T, Miyasaka K, Shimizu T, Kawakami Y. Dosakaakita H, et al. Among authors: miyamoto h. Int J Oncol. 1997 Aug;11(2):371-5. doi: 10.3892/ijo.11.2.371. Int J Oncol. 1997. PMID: 21528224

8

[Cytogenetic analysis of lung tumors by in situ hybridization with chromosome-specific DNA probes].

Miyamoto H, Kato M, Ishikuro A, Akita H, Kawakami Y. Miyamoto H, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30 Suppl:33-8. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1306236 Japanese.

9

Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer.

Harada M, Dosaka-Akita H, Miyamoto H, Kuzumaki N, Kawakami Y. Harada M, et al. Among authors: miyamoto h. Cancer. 1992 Jan 1;69(1):72-7. doi: 10.1002/1097-0142(19920101)69:1<72::aid-cncr2820690114>3.0.co;2-a. Cancer. 1992. PMID: 1309311

10

Reduced drug accumulation in a newly established human lung squamous-carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

Katabami M, Fijita H, Haneda H, Akita H, Kuzumaki N, Miyamoto H, Kawakami Y. Katabami M, et al. Among authors: miyamoto h. Biochem Pharmacol. 1992 Jul 22;44(2):394-7. doi: 10.1016/0006-2952(92)90027-g. Biochem Pharmacol. 1992. PMID: 1642651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,925 results

Search Page

Filters